|
1
|
Jochems A, El-Naqa I, Kessler M, Mayo CS,
Jolly S, Matuszak M, Faivre-Finn C, Price G, Holloway L, Vinod S,
et al: A prediction model for early death in non-small cell lung
cancer patients following curative-intent chemoradiotherapy. Acta
Oncol. 57:226–230. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roengvoraphoj O, Wijaya C, Eze C, Li M,
Dantes M, Taugner J, Tufman A, Huber RM, Belka C and Manapov F:
Analysis of primary tumor metabolic volume during chemoradiotherapy
in locally advanced non-small cell lung cancer. Strahlenther Onkol.
194:107–115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guilbault C, Garant A, Faria S, Owen S,
Ofiara L, Duclos M, Hirsh V and Kopek N: Long-term outcomes of
induction carboplatin and gemcitabine followed by concurrent
radiotherapy with low-dose paclitaxel and gemcitabine for stage III
non-small-cell lung cancer. Clin Lung Cancer. 18:565–571. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morgensztern D, Ng SH, Gao F and Govindan
R: Trends in stage distribution for patients with non-small cell
lung cancer: A National Cancer Database survey. J Thorac Oncol.
5:29–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang N, Dong XP, Zhang SL, You QY, Jiang
XT and Zhao XG: Triptolide reverses the Taxol resistance of lung
adenocarcinoma by inhibiting the NF-κB signaling pathway and the
expression of NF-κB-regulated drug-resistant genes. Mol Med Rep.
13:153–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu R, Liu X, Zheng Y, Gu J, Xiong S,
Jiang P, Jiang X, Huang E, Yang Y, Ge D and Chu Y: MicroRNA-7
sensitizes non-small cell lung cancer cells to paclitaxel. Oncol
Lett. 8:2193–2200. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holleman A, Chung I, Olsen RR, Kwak B,
Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE and Zetter BR:
miR-135a contributes to paclitaxel resistance in tumor cells both
in vitro and in vivo. Oncogene. 30:4386–4398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Datta S, Choudhury D, Das A, Das Mukherjee
D, Das N, Roy SS and Chakrabarti G: Paclitaxel resistance
development is associated with biphasic changes in reactive oxygen
species, mitochondrial membrane potential and autophagy with
elevated energy production capacity in lung cancer cells: A
chronological study. Tumour Biol. 39:10104283176943142017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun QL, Sha HF, Yang XH, Bao GL, Lu J and
Xie YY: Comparative proteomic analysis of paclitaxel sensitive A549
lung adenocarcinoma cell line and its resistant counterpart
A549-taxol. J Cancer Res Clin Oncol. 137:521–532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Azuma Y, Yokobori T, Mogi A, Altan B,
Yajima T, Kosaka T, Onozato R, Yamaki E, Asao T, Nishiyama M and
Kuwano H: SIRT6 expression is associated with poor prognosis and
chemosensitivity in patients with non-small cell lung cancer. J
Surg Oncol. 112:231–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu B, Pan CF, Ma T, Wang J, Yao GL, Wei K
and Chen YJ: Long non-coding RNA AK001796 contributes to cisplatin
resistance of non-small cell lung cancer. Mol Med Rep.
16:4107–4112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee H, Kim C, Ku JL, Kim W, Yoon SK, Kuh
HJ, Lee JH, Nam SW and Lee EK: A long non-coding RNA snaR
contributes to 5-fluorouracil resistance in human colon cancer
cells. Mol Cells. 37:540–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21(WAF1/CIP1) expression. PLoS One.
8:e772932013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong S, Qu X, Li W, Zhong X, Li P, Yang S,
Chen X, Shao M and Zhang L: The long non-coding RNA, GAS5, enhances
gefitinib-induced cell death in innate EGFR tyrosine kinase
inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR
via downregulation of the IGF-1R expression. J Hematol Oncol.
8:432015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi Y, Lv C, Shi L and Tu G: MEG3 inhibits
proliferation and invasion and promotes apoptosis of human
osteosarcoma cells. Oncol Lett. 15:1917–1923. 2018.PubMed/NCBI
|
|
18
|
Xia Y, He Z, Liu B, Wang P and Chen Y:
Downregulation of Meg3 enhances cisplatin resistance of lung cancer
cells through activation of the WNT/β-catenin signaling pathway.
Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian X, Zhang H, Zhang B, Zhao J, Li T and
Zhao Y: Microarray expression profile of long non-coding RNAs in
paclitaxel-resistant human lung adenocarcinoma cells. Oncol Rep.
38:293–300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: American Joint Committee on Cancer (AJCC). AJCC
Cancer Staging Manual. 8th. Springer; New York, NY: 2017,
View Article : Google Scholar
|
|
23
|
Jiang B, Liu J, Zhang YH, Shen D, Liu S,
Lin F, Su J, Lin QF, Yan S, Li Y, et al: Long noncoding RNA
LINC00961 inhibits cell invasion and metastasis in human non-small
cell lung cancer. Biomed Pharmacother. 97:1311–1318. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang W, Yuan W, Song J, Wang S and Gu X:
lncRna CPS1-IT1 suppresses cell proliferation, invasion and
metastasis in colorectal cancer. Cell Physiol Biochem. 44:567–580.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Zhang M, An G and Ma Q: lncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo Y, Xuan Z, Zhu X, Zhan P and Wang Z:
Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9
were associated with the prognosis of lung squamous cell carcinoma.
Mol Med Rep. 17:7238–7248. 2018.PubMed/NCBI
|
|
27
|
Chen Y, Wei G, Xia H, Tang Q and Bi F:
Long noncoding RNA-ATB promotes cell proliferation, migration and
invasion in gastric cancer. Mol Med Rep. 17:1940–1946.
2018.PubMed/NCBI
|
|
28
|
Ding J, Li D, Gong M, Wang J, Huang X, Wu
T and Wang C: Expression and clinical significance of the long
non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther.
7:1625–1630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ren K, Xu R, Huang J, Zhao J and Shi W:
Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance
to paclitaxel in lung adenocarcinoma. Cancer Chemother Pharmacol.
80:243–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Q, Zhang W and Hao S: lncRNA CCAT1
modulates the sensitivity of paclitaxel in nasopharynx cancers
cells via miR-181a/CPEB2 axis. Cell Cycle. 16:795–801. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren S, Li G, Liu C, Cai T, Su Z, Wei M,
She L, Tian Y, Qiu Y, Zhang X, et al: Next generation deep
sequencing identified a novel lncRNA n375709 associated with
paclitaxel resistance in nasopharyngeal carcinoma. Oncol Rep.
36:1861–1867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu J, Wu J, Fu C, Teng F, Liu S, Dai C,
Shen R and Jia X: Multidrug resistant lncRNA profile
inchemotherapeutic sensitive and resistant ovarian cancer cells. J
Cell Physiol. 233:5034–5043. 2018. View Article : Google Scholar : PubMed/NCBI
|
